| Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease P Kesarwani, AK Murali, AA Al-Khami, S Mehrotra Antioxidants & redox signaling 18 (12), 1497-1534, 2013 | 249 | 2013 |
| Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment S Kant, P Kesarwani, A Prabhu, SF Graham, KL Buelow, I Nakano, ... Cell Death & Disease 11 (4), 253, 2020 | 104 | 2020 |
| Anti-and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in … D Ahirwar, P Kesarwani, PK Manchanda, A Mandhani, RD Mittal Cancer genetics and cytogenetics 184 (1), 1-8, 2008 | 81 | 2008 |
| Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors S Chatterjee, K Thyagarajan, P Kesarwani, JH Song, M Soloshchenko, ... Cancer research 74 (21), 6048-6059, 2014 | 66 | 2014 |
| Tryptophan metabolism contributes to radiation-induced immune checkpoint reactivation in glioblastoma P Kesarwani, A Prabhu, S Kant, P Kumar, SF Graham, KL Buelow, ... Clinical Cancer Research 24 (15), 3632-3643, 2018 | 65 | 2018 |
| Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma P Kesarwani, A Prabhu, S Kant, P Chinnaiyan Cancer Immunology, Immunotherapy 68, 1107-1120, 2019 | 58 | 2019 |
| The interplay between metabolic remodeling and immune regulation in glioblastoma P Kesarwani, S Kant, A Prabhu, P Chinnaiyan Neuro-oncology 19 (10), 1308-1315, 2017 | 53 | 2017 |
| XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy R Devi Mittal, R Singh, P Kaur Manchanda, D Ahirwar, R Gangwar, ... Cancer biology & therapy 7 (5), 645-650, 2008 | 51 | 2008 |
| Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells MP Rubinstein, EW Su, S Suriano, CA Cloud, K Andrijauskaite, ... Cancer Immunology, Immunotherapy 64, 539-549, 2015 | 49 | 2015 |
| Promoting thiol expression increases the durability of antitumor T-cell functions P Kesarwani, AA Al-Khami, G Scurti, K Thyagarajan, N Kaur, S Husain, ... Cancer research 74 (21), 6036-6047, 2014 | 47 | 2014 |
| Immunotherapy and radiation in glioblastoma S Sahebjam, A Sharabi, M Lim, P Kesarwani, P Chinnaiyan Journal of neuro-oncology 134, 531-539, 2017 | 42 | 2017 |
| IL-10 −1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort P Kesarwani, DK Ahirwar, A Mandhani, AN Singh, D Dalela, ... World journal of urology 27, 389-396, 2009 | 40 | 2009 |
| Association between −174 G/C Promoter Polymorphism of the Interleukin-6 Gene and Progression of Prostate Cancer in North Indian Population P Kesarwani, DK Ahirwar, A Mandhani, RD Mittal DNA and cell biology 27 (9), 505-510, 2008 | 40 | 2008 |
| Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells P Chakraborty, S Chatterjee, P Kesarwani, K Thyagarajan, S Iamsawat, ... Journal of Biological Chemistry 294 (23), 9198-9212, 2019 | 39 | 2019 |
| Lack of p53 augments antitumor functions in cytolytic T cells A Banerjee, K Thyagarajan, S Chatterjee, P Chakraborty, P Kesarwani, ... Cancer research 76 (18), 5229-5240, 2016 | 39 | 2016 |
| Association of tumour necrosis factor‐α gene (T‐1031C, C‐863A, and C‐857T) polymorphisms with bladder cancer susceptibility and outcome after bacille … DK Ahirwar, A Mandhani, A Dharaskar, P Kesarwani, RD Mittal BJU international 104 (6), 867-873, 2009 | 38 | 2009 |
| Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma AH Prabhu, S Kant, P Kesarwani, K Ahmed, P Forsyth, I Nakano, ... Neuro-oncology 21 (3), 337-347, 2019 | 37 | 2019 |
| Dietary Agents in Cancer Prevention: An Immunological Perspective† YY Zheng, B Viswanathan, P Kesarwani, S Mehrotra Photochemistry and photobiology 88 (5), 1083-1098, 2012 | 36 | 2012 |
| Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer P Kesarwani, RK Mandal, R Maheshwari, RD Mittal BJU international 107 (3), 471-476, 2011 | 36 | 2011 |
| Inhibition of colony-stimulating factor-1 receptor enhances the efficacy of radiotherapy and reduces immune suppression in glioblastoma MF Almahariq, TJ Quinn, P Kesarwani, S Kant, CR Miller, P Chinnaiyan In Vivo 35 (1), 119-129, 2021 | 34 | 2021 |
SHIKHAR MEHROTRAMedical University of South CarolinaE-mail megerősítve itt: musc.edu